Global Opioids Market to Grow at 2.8% During 2024-2032, Impelled by Increasing Number of Individuals Undergoing Surgeries

December 06, 2021 | Healthcare

The latest report by IMARC Group, titled “Opioids Market Report by Product Type (Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone), Application (Pain Management, Cough Treatment, Diarrhea Treatment, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Stores, and Others), and Region 2024-2032,” finds that the global opioids market size reached US$ 21.9 Billion in 2023. Opioids refer to naturally occurring, synthetic, or semi-synthetic drugs that interact with opioid receptors in the nervous system and activate them. These potent medicines include morphine, codeine, oxycodone, hydrocodone, and methadone. They decrease the pain of treatments and injuries by preventing the pain signals from reaching other parts of the body. Opioids can be administered through intravenous (IV) injection or taken through oral and transdermal routes. They are prescribed by healthcare professionals as they are safe, cost-effective and easily available. As a result, they are majorly used to treat the pain associated with rheumatic diseases, cancer, anxiety, sleep disorder, and severe pain related to coughing and diarrhea.

Global Opioids Market Trends:

The market is primarily driven by the increasing prevalence of chronic pain associated with diseases such as cancer, arthritis, lower back pain, fibromyalgia, and post-surgical pain. Opioids are standard practice in most parts of the world as an effective way of managing chronic pain. In addition to this, the rising consumption of alcohol and tobacco, coupled with the occurrences of obesity, human papillomavirus (HPV) and multiple sunburns are also propelling the market growth. Furthermore, the growing number of individuals undergoing surgery has positively influenced the demand for opioids, especially in controlling post-surgical pain, speedy recovery, and reducing the chances of complications in patients. Moreover, the rising focus on the abuse-deterrent formulation (ADF) by generic manufacturers has resulted in the introduction of new opioid variants, which, in turn, is escalating their demand as effective drugs for pain management. Looking forward, the market is expected to grow at a CAGR of 2.8% during the forecast period (2024-2032).

Market Summary:

Based on the product type, the market has been segmented into codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone.
On the basis of the application, the market has been classified into pain management, cough treatment, diarrhea treatment, and others.
The market has been categorized based on the distribution channel into hospital pharmacies, retail pharmacies, drug stores, online stores, and others.
Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
The competitive landscape of the market has been examined, with some of the key players being Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Limited.

Report Coverage:

Report Features	Details
Base Year of the Analysis	2023
Historical Period	2018-2023
Forecast Period	2024-2032
Units	US$ Billion
Segment Coverage	Product Type, Application, Distribution Channel, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 3899 Five User License: US$ 4899 Corporate License: US$ 5899
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Opioids Market to Grow at 2.8% During 2024-2032, Impelled by Increasing Number of Individuals Undergoing Surgeries

Purchase options

Single User License ~~$3899~~ $2999
Five User License ~~$4899~~ $3999
Corporate User License ~~$5899~~ $4999

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.